TimesSquare Capital Management LLC bought a new position in shares of Signify Health, Inc. (NYSE:SGFY) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 71,100 shares of the company’s stock, valued at approximately $2,080,000.
Other hedge funds have also modified their holdings of the company. Compagnie Lombard Odier SCmA purchased a new position in shares of Signify Health during the 1st quarter worth approximately $5,288,000. Treasurer of the State of North Carolina purchased a new position in Signify Health in the 1st quarter valued at approximately $241,000. Levin Capital Strategies L.P. purchased a new position in Signify Health in the 1st quarter valued at approximately $351,000. Integral Health Asset Management LLC purchased a new position in Signify Health in the 1st quarter valued at approximately $4,682,000. Finally, Quantitative Systematic Strategies LLC purchased a new position in Signify Health in the 1st quarter valued at approximately $546,000.
Several equities analysts recently weighed in on the company. Barclays assumed coverage on Signify Health in a research note on Monday, March 8th. They issued an “equal weight” rating and a $30.00 price objective for the company. Piper Sandler assumed coverage on Signify Health in a report on Monday, March 8th. They set an “overweight” rating and a $42.00 target price on the stock. Deutsche Bank Aktiengesellschaft increased their target price on Signify Health from $35.00 to $39.00 and gave the company a “buy” rating in a report on Friday, March 26th. William Blair assumed coverage on Signify Health in a report on Monday, March 8th. They set an “outperform” rating on the stock. Finally, Bank of America assumed coverage on Signify Health in a report on Monday, March 8th. They set a “buy” rating and a $34.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $34.29.
Signify Health (NYSE:SGFY) last posted its quarterly earnings data on Tuesday, May 11th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.24. The business had revenue of $180.00 million for the quarter, compared to analyst estimates of $169.53 million. As a group, equities research analysts predict that Signify Health, Inc. will post 0.2 EPS for the current fiscal year.
Signify Health Profile
Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.
Recommended Story: Why do analysts give a neutral rating?
Receive News & Ratings for Signify Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Signify Health and related companies with MarketBeat.com's FREE daily email newsletter.